Aurora Cannabis sees record Q4-2025 revenues driven by international sales, but low profits and weak 2026 outlook keep stock ...

Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its ...

Aurora Cannabis faces headwinds as Q4/FY2025 revenues grow but profitability declines due to one-time expenses. Check out why ...

Aurora's CEO defends partnership with PMI-owned Aspeya, saying it's about science, not Big Tobacco. Here's what we learned.

Q4 2025 Earnings Call Transcript June 18, 2025 Aurora Cannabis Inc. misses on earnings expectations. Reported EPS is $0.07 ...

Aurora CEO says medical cannabis is profitable and growing—even if investors aren't seeing it yet. Here's what's driving the ...

Aurora Cannabis ( Aurora Cannabis Stock Quote, Chart, News, Analysts, Financials TSX:ACB) reported stronger fourth-quarter ...

Aurora Cannabis Inc (TSX:ACB) is set to release its Q4 2025 earnings on June 18, 2025. The consensus estimate for Q4 2025 ...

An Edmonton-based cannabis company is cleaning up a mess left behind by an investing site that erroneously published ...

Aurora Cannabis (TSX:ACB) issued a firm denial of recent misinformation circulating online regarding alleged acquisitions and ...

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of a second instance of misinformation posted on ...

Canadian operator Aurora Cannabis on Wednesday denied reports that it had agreed to acquire New Zealand-based MedLeaf Therapeutics.